Coronavirus disease 2019 (COVID-19) and prosthetic heart valve: An additional coagulative challenge.
作者信息
Allione Attilio, Giamello Jacopo Davide, Bernardi Sara, Paglietta Giulia, Cavalot Giulia Lucia Massimina, Dutto Luca Alessio, Caruso Daniela, Tortore Andrea, Lauria Giuseppe
机构信息
Department of Emergency Medicine, Santa Croce and Carle Hospital, Cuneo, Italy.
School of Emergency Medicine, University of Turin, Turin, Italy.
出版信息
World J Emerg Med. 2020;11(4):258-259. doi: 10.5847/wjem.j.1920-8642.2020.04.009.
Abstract
摘要
相似文献
1
Coronavirus disease 2019 (COVID-19) and prosthetic heart valve: An additional coagulative challenge.2019冠状病毒病（COVID-19）与人工心脏瓣膜：又一个凝血方面的挑战。
World J Emerg Med. 2020;11(4):258-259. doi: 10.5847/wjem.j.1920-8642.2020.04.009.
2
Echocardiographic assessment of prosthetic heart valves.心脏瓣膜假体的超声心动图评估。
Prog Cardiovasc Dis. 2014 Jul-Aug;57(1):100-10. doi: 10.1016/j.pcad.2014.05.001. Epub 2014 May 21.
3
Prosthetic heart valve thrombosis: an overview.人工心脏瓣膜血栓形成：概述
WMJ. 2002;101(7):67-9.
4
Clinical significance of congestive heart failure in prosthetic valve endocarditis. A multicenter study with 257 patients.人工瓣膜心内膜炎中充血性心力衰竭的临床意义。一项纳入257例患者的多中心研究。
Rev Esp Cardiol (Engl Ed). 2013 May;66(5):384-90. doi: 10.1016/j.rec.2012.10.022. Epub 2013 Feb 22.
5
Patient self-monitoring of prosthetic heart valve function.患者对人工心脏瓣膜功能的自我监测。
J Heart Valve Dis. 2007 Sep;16(5):558-66.
6
Intermittent Malfunction of a Prosthetic Valve-A Diagnostic Challenge.人工瓣膜间歇性故障——一项诊断挑战
Echocardiography. 2016 Jun;33(6):916-9. doi: 10.1111/echo.13210. Epub 2016 Mar 16.
7
Prosthetic valve endocarditis: clinicopathologic analysis of 22 necropsy patients with comparison observations in 74 necropsy patients with active infective endocarditis involving natural left-sided cardiac valves.人工瓣膜心内膜炎：22例尸检患者的临床病理分析，并与74例累及天然左侧心脏瓣膜的活动性感染性心内膜炎尸检患者进行对比观察。
Am J Cardiol. 1976 Sep;38(3):281-92. doi: 10.1016/0002-9149(76)90169-7.
8
Does the Use of a Decision Aid Improve Decision Making in Prosthetic Heart Valve Selection? A Multicenter Randomized Trial.使用决策辅助工具能否改善人工心脏瓣膜选择中的决策制定？一项多中心随机试验。
Circ Cardiovasc Qual Outcomes. 2017 Feb;10(2). doi: 10.1161/CIRCOUTCOMES.116.003178. Epub 2017 Feb 22.
9
10
Diagnostic value of D-dimer and antithrombin-III levels in predicting prosthetic heart valve thrombosis.D - 二聚体和抗凝血酶 - III水平在预测人工心脏瓣膜血栓形成中的诊断价值
Tex Heart Inst J. 2003;30(4):268-79.
引用本文的文献
1
Comparison of clinical characteristics in patients with coronavirus disease and influenza A in Guangzhou, China.中国广州新冠肺炎患者与甲型流感患者临床特征比较。
World J Emerg Med. 2021;12(4):287-292. doi: 10.5847/wjem.j.1920-8642.2021.04.006.
2
Identifying critically ill patients at risk of death from coronavirus disease.识别有死于冠状病毒病风险的重症患者。
World J Emerg Med. 2021;12(1):18-23. doi: 10.5847/wjem.j.1920-8642.2021.01.003.
本文引用的文献
1
COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure.COVID-19 相关严重高凝状态与急性呼吸衰竭入住重症监护病房患者。
Thromb Haemost. 2020 Jun;120(6):998-1000. doi: 10.1055/s-0040-1710018. Epub 2020 Apr 21.
2
Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients.在 SARS-CoV-2 住院患者中，将口服抗凝剂转换为普通肝素。
Intern Emerg Med. 2020 Aug;15(5):751-753. doi: 10.1007/s11739-020-02331-1. Epub 2020 Apr 15.
3
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
4
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET).新型冠状病毒肺炎与止血：来自意大利血栓形成与止血协会（SISET）的立场文件。
Blood Transfus. 2020 May;18(3):167-169. doi: 10.2450/2020.0083-20. Epub 2020 Apr 8.
5
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
6
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病：考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
7
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.SARS-CoV-2 感染患者凝血功能的显著变化。
Clin Chem Lab Med. 2020 Jun 25;58(7):1116-1120. doi: 10.1515/cclm-2020-0188.
8
Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.瓣膜疾病的抗栓和溶栓治疗：抗栓治疗与血栓预防，第 9 版：美国胸科医师学院循证临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e576S-e600S. doi: 10.1378/chest.11-2305.
9
Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation.低分子量肝素与持续输注普通肝素用于机械人工瓣膜植入术后启动抗凝治疗的疗效、安全性及成本比较。
Am J Cardiol. 2004 Jan 15;93(2):247-50. doi: 10.1016/j.amjcard.2003.09.054.
Zotero 插件